News

A new population study published in Redox Biology has established reference ranges for NAD and...

NADMED has appointed James Lee as its new Chief Executive Officer, effective from the beginning of...

We are proud to announce that Dr. Keyue Sun and the Schlegel Lab have been selected as the...

NADMED has partnered with London-based Altheome Labs to expand access to advanced NAD testing in...

A new abstract, presented at the American Stroke Association’s Conference, explores how NAD and...

A study in Cell Reports Medicine shows significantly lower NAD+ levels in the brains of...